Replies to post #137224 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Recieve approval for that then following these patients and measuring other improvements in those patients as well as the ones formally in the trial to support an expanding label for A2-73 if other improvements are seen beyond the symptomatic improvements in sleep ,mood and others symptoms.
Make in effect a trial that started with a small n into one of a large n by following patients taking A2-73 Phase 4 style.

Your suggestion fits well with the new guidance.